College of Pharmacy and Pharmaceutical Sciences, Florida A and M University, Tallahassee, FL 32307, USA.
Mol Med Rep. 2012 Feb;5(2):513-6. doi: 10.3892/mmr.2011.677. Epub 2011 Nov 15.
The µ-opioid receptor is the primary site for the action of morphine. In the present study, we investigated the regulation of the µ-opioid receptor mRNA levels in the locus ceruleus, ventral tegmental area, nucleus accumbens and hypothalamus of the rat brain following intracerebroventricular administration of morphine for 7 days. The isolated mRNA from these regions was subjected to real-time quantitative RT-PCR to determine the regulation of µ-opioid receptor gene expression. It was observed that 7 days of treatment with morphine significantly down-regulated the µ-opioid receptor mRNA levels in the hypothalamus of the brain in comparison to the control group. However, the µ-opioid receptor levels in the locus ceruleus, ventral tegmental area and nucleus accumbens regions remained the same as the control levels. Down-regulation of µ-opioid receptor mRNA levels in the hypothalamus region of the brain indicates the probable role of opioids to influence neuroendocrine function. The results further indicate that cellular adaptation for morphine tolerance is tissue-specific. These findings help us to understand the mechanism of morphine tolerance in various regions of the brain.
μ 阿片受体是吗啡作用的主要部位。在本研究中,我们研究了连续 7 天侧脑室给予吗啡后大鼠脑蓝斑、腹侧被盖区、伏隔核和下丘脑 μ 阿片受体 mRNA 水平的调节。用实时定量 RT-PCR 检测这些区域分离的 mRNA,以确定 μ 阿片受体基因表达的调节。结果表明,与对照组相比,7 天的吗啡治疗显著下调了大脑下丘脑的 μ 阿片受体 mRNA 水平。然而,蓝斑、腹侧被盖区和伏隔核区域的 μ 阿片受体水平与对照组水平相同。大脑下丘脑 μ 阿片受体 mRNA 水平的下调表明阿片类药物可能影响神经内分泌功能。结果进一步表明,吗啡耐受的细胞适应是组织特异性的。这些发现有助于我们了解大脑各区域吗啡耐受的机制。